28.3 C
Vientiane
Sunday, July 20, 2025
spot_img
Home Blog Page 2507

DHL Express Singapore Spearheads Sustainable Logistics with 80 Additional Electric Vehicles

This makes DHL Express Singapore the first logistics provider in Singapore to transition to a commercial EV fleet of this scale through its partnership with ComfortDelGro

SINGAPORE – Media OutReach21 June 2022 – DHL Express, the world’s leading international express service provider, today announced the addition of 80 electric vehicles (EVs) to its Singapore fleet, in partnership with ComfortDelGro, one of the world’s largest land transport companies. Together with the 10 EVs that are currently in its fleet, DHL Express Singapore will have a total of 90 EVs on Singapore roads by October 2022. This eight-fold increase in the number of operational EVs will make DHL Express Singapore the first logistics provider in the country to transition to a commercial EV fleet of this scale.

At a launch ceremony today graced by Mr. S. Iswaran, Minister for Transport, DHL Express Singapore also announced that it will be investing close to SGD 8 million into electrifying its fleet over the next five years. Part of this investment amount goes towards a five-year EV leasing and maintenance agreement with ComfortDelGro’s car leasing subsidiary, ComfortDelGro Rent-A-Car Pte Ltd for 80 electric vans. Another part of the investment will support the installation of 105 charging points across its service centers, and 25 more EVs of other vehicle types that will support other areas of operations, such as shipment distribution across its facilities. The 25 other EVs will be added in the next 12 months.

Ken Lee, CEO, DHL Express Asia Pacific, said, “We are on a journey towards achieving net-zero emissions by 2050 with a focus on clean operations. As a leader in express logistics, we have a responsibility to guide and influence the industry to reduce carbon footprint across logistics operations. Globally, we have made significant progress in sustainable aviation with our partnership with Neste and bp on sustainable aviation fuel. Today’s electric vehicle fleet expansion marks another huge step forward as we green our land transport.”

The new EVs will replace internal combustion engine (ICE) vans as part of DHL Express Singapore’s fleet renewal exercise to drive sustainable logistics and support its sustainability roadmap. The rollout also further demonstrates DHL Express’ ongoing commitment to build cleaner and greener logistics operations in Asia Pacific. Aside from staying true to DHL’s sustainability commitment, the change to EVs is also aligned with Singapore’s 2030 Green Plan, which aims to put more EVs on Singapore’s roads.

Christopher Ong, Managing Director, DHL Express Singapore, said, “We are excited to be taking a bold step towards our sustainability goals and to be charging up for a greener future. By transitioning to electric vehicles, DHL Express Singapore is set to eliminate a total of 323 tons of CO2 emissions yearly, and this is just the beginning for us. We look forward to staying true to our Mission 2050 goal and continuing to connect people and improve lives in a greener future.”

Mary Ong, CEO, ComfortDelGro Rent-A-Car, said, “ComfortDelGro Rent-A-Car and DHL Express Singapore has had more than 20 years of partnership. We are therefore excited to be a part of its sustainability journey of integrating EVs into its fleet. We hope that with the leasing of that many Citroën ë-Dispatch vehicles to DHL, our partnership will grow from strength to strength.”

Cycle & Carriage is the authorized distributor of the chosen van model, Citroën ë-Dispatch; Siemens VersiCharge AC charger will be installed across DHL Express service centers by EV charger service provider EVOne for the EV fleet.

These EVs can travel a distance of up to 339km and have cargo space of up to 5.3m³ with a payload of 1000kg. They can be charged from 0% to 80% in 48 minutes and are equipped with driver assistance features such as hill-start assist, an anti-lock braking system, and an electronic stability program. These driver features will also enhance the safety and driving experience for the couriers on the road.

Smart charging points at DHL Express service centers will provide daily charge required by the EVs. These charging points have special capabilities such as an anti-EV hogging monitoring system, and an EV model or license plate recognition system which allows operations staff to make effective use of available charging points.

DHL – The logistics company for the world

DHL is the leading global brand in the logistics industry. Our DHL divisions offer an unrivalled portfolio of logistics services ranging from national and international parcel delivery, e-commerce shipping and fulfillment solutions, international express, road, air and ocean transport to industrial supply chain management. With about 380,000 employees in more than 220 countries and territories worldwide, DHL connects people and businesses securely and reliably, enabling global sustainable trade flows. With specialized solutions for growth markets and industries including technology, life sciences and healthcare, engineering, manufacturing & energy, auto-mobility and retail, DHL is decisively positioned as “The logistics company for the world”.

DHL is part of Deutsche Post DHL Group. The Group generated revenues of more than 81 billion euros in 2021. With sustainable business practices and a commitment to society and the environment, the Group makes a positive contribution to the world. Deutsche Post DHL Group aims to achieve zero-emissions logistics by 2050.

On the Internet: ;
Follow us at: ;

#DHL

Lao Government Collects Revenues from Cryptocurrency

Cryptocurrency.

The government has collected revenue from cryptocurrency companies through a trial of cryptocurrency mining, a new process for Laos.

7-Eleven x Tiger Beer unveils Singapore’s first beachfront store in Sentosa

Exciting new beachfront store on the sands of popular Palawan beach is now open – bringing beachside convenience to even more locals and tourists alike!

SINGAPORE – Media OutReach – 21 June 2022 – Singapore’s favourite convenience store, 7-Eleven, and the country’s favourite, Tiger Beer, have joined forces to unveil the very first beachfront convenience store right on the sands of Palawan Beach Walk, Sentosa! On 25th and 26th June, the first-of-its-kind store will kick off opening celebrations with a variety of promotions and special treats for families enjoying the last weekend of the school holidays and for young adults and tourists who have made hanging out on the beaches of Sentosa their highlight of the week.

7-Eleven Store Front View

7-Eleven Store Front View

Perched right on the sands of the popular Palawan beach, this instagrammable 7-Eleven store can be spotted from afar with its vibrant murals and unique graffiti artwork on its facade. This exciting store offers ice-cold Tiger beer on reverse tap, exclusive Nitro Tea and icy Arctic Coke to help beat the heat, of course, along with 7-Eleven’s all-time favourites – Slurpee, Mr. Softee and 7CAFÉ. Guests can enjoy their refreshing drinks, hot snacks and even ready-to-eat meals at the special 7-Eleven x Tiger Beer chillout area on the sands or at their favourite beach spot.

Ice-cold Tiger Beer Quick and Easy

To help people get their drinks fast, 7-Eleven and Tiger Beer will be bringing a special reverse tap bar, which will automatically dispense the right pour of beer in each cup consistently – without needing a bartender. The reverse tap dispenser is fast, convenient and easy, giving you more time to spend soaking up the sun.

Stay cool in the heat with outlet-exclusive Nitro Tea and brain-freezing Coke slushies

7-Eleven’s Sentosa Palawan Beach store will also be introducing the new and exclusive Nitro Tea. Choose between a refreshing black tea or a variety of caffeine-free fruit teas to give your taste buds a high-five. Either way, you will experience a rich, dairy-free creamy foam, refreshing and longer-lasting flavour, and sweetness without the added calories – thanks to the nitrogen infusion that gives beverages a sweet taste without added sweeteners.

7-Eleven will also be bringing the unique Arctic Coke machine to Palawan Beach! Simply choose your bottle of Coca-Cola, put it into the machine and press a button – in no time, you will have an icy cold Coke slushie to give you a brain freeze that will refresh your mind for the week ahead.

Carefree snacking with grab-and-go hot bites and Ready-to-Eat meals by the beach

Beachgoers who feel peckish after sun and surf will also be able to get delicious warm pastries and finger food from the hot food counter. Savoury hot food items include fried chicken selections from super crispy chicken to savoury chicken drumsticks and wings, while those who long for buttery pastries can expect offerings such as Butter Croissant, Cocoa Hazelnut Croissant, Pain Au Raisin, Tomato Cheese Tart, Mini doughnuts, Pure Butter Madeleine and Citrus Madeleine. Ready-to-Eat meals will also be available for those who need more filling up, an affordable alternative to the pricier options in the area.

Mark your calendars and celebrate the opening with us on 25 and 26 June!

Savour the last weekend of the June school holidays with an unforgettable carnival-inspired blast on the beach with family and friends at the 7-Eleven’s Sentosa Palawan Beach store on 25 and 26 June 2022 from 10am onwards.

Customers can enjoy free popcorn, 7-Eleven balloons, face painting activities, Häagen-Dazs or Walls ice cream (first 200 customers, with any purchase), Mr. Softee (100 cups a day), chances to walk away with exciting Spin and Win rewards (with a minimum spend of $7, list of prizes in table below*), and last but not least, live music performed by local singer-busker Jeff Ng, who recently made headlines for his popular weekly busking at The Cathay!

Customers can also look forward to the following deals:

Promotion Promotional period Details
Spin and Win prizes* (with a minimum spend of $7) 25 and 26 June 2022 ● Sentosa premium merchandise such as luggage tags and tote bags

● $5 Dairy Farm vouchers

● $10 Dairy Farm vouchers

● Jinro Hite Tonic Water 250ml FOC

● Vaseline HB SPF 24 Sun + Pol E 100ml

● Asian Delight Sea Coconut

● Lays Max BBQ potato chips 73g

● Authentic Tea House Ceylon Tea 500ml

● Seaweed Wasabi Cashew Mix Macadamia 35g

Slurpee and Nitro Tea 25 June – 3 July 2022 ● Slurpee Large 16oz at promo price $1.50 (normal RSP $1.80) 25 and 26 June

● Nitro Tea BOGO – applicable for both flavours

Tiger Beer 25 June – 22 July 2022 ● Buy 5 reverse tap cups of beer at a go and get 1 free Tiger Crystal 49cl can

● While stocks last

Tiger Beer gift with purchase 23 July – 19 August 2022 ● Buy 3 reverse tap cups of beer and get 1 free Elegante glass*

● Buy 6 reverse tap cups of beer and get 1 free Elegante glass and 1 slipper-shaped floatie* [1m (W) x 1.5m (H)]

*Limited quantity of 200 each

More promotions and updates can also be found on the official 7-Eleven Singapore Facebook and 7-Eleven Singapore Instagram pages.

“7-Eleven is reimagining convenience at the beach with our first beachfront store at Sentosa, in collaboration with Singapore’s iconic brand Tiger Beer. From the Arctic Coke machine to the exclusive Nitro Tea, and Reverse Tap beer and the Tiger Beer chill out zone, our new store offers a lot of exciting things for beach loving families, young adults and tourists, and we look forward to welcoming them! We hope that customers will be able to enjoy our new concept store with its unique design and special murals,” said Mr. Steven Lye, Managing Director of 7-Eleven Singapore.

“This is a great collaboration with 7-Eleven where we pushed the boundaries and found innovative ways to uncage the ultimate refreshment for our consumers. Tiger has a special bond with beer-lovers, and we believe that the beachfront store at Sentosa Palawan Beach would energise the experience by bringing consumers the smoothest beer and greatest vibes,” said Yogender Sharma, Marketing Manager of Asia Pacific Breweries Singapore.

“We are delighted to be home to Singapore’s first-ever 7-Eleven store by the beach. This new store concept is an example of the novel and imaginative experience that we are curating for our guests on our beach. Apart from providing the convenience of getting beach essentials, the store is also a unique beachfront bistro where guests can pick up a quick and affordable meal. We welcome this partnership with 7-Eleven in enhancing our guests’ experience as they enjoy their day on Sentosa, ” said Mr Chew Tiong Heng, Divisional Director (Business and Experience Development), Sentosa Development Corporation.

High-res images of the 7-Eleven Sentosa Palawan Beach store are available here.

About 7-Eleven

Established in Singapore in 1983, 7-Eleven has since expanded to more than 400 stores island-wide to become the leading 24-hour convenience chain store. We take pride in serving the Singapore community 24 hours a day, 365 days a year. 7-Eleven emphasises convenience and value by offering a wide array of quality products, food and services to satisfy the needs of its customers. Think 7-Eleven and what comes to mind are the refreshing Slurpee, 7CAFÉ as well as a wide range of quality ready meals and sandwiches under 7-SELECT. 7-Eleven is also a 24/7 one-stop destination for customers who need to access bill payment services in their own time. Our services cover payment of utilities, courier services, and even cash withdrawal. For more information, visit

About Tiger Beer
Tiger Beer was born in 1932 on the streets of Singapore. Today, Tiger Beer is the number one Asia premium beer and one of the fastest growing brands that is currently available in more than 50 markets across the globe. Tiger Beer believes great ideas and talent are not born in the boardroom but born on the streets of the world. Therefore, Tiger Beer is committed to championing local talents who approach their craft in unconventional ways. Tiger Beer continues to support these talents by uncaging unexpected possibilities for them. For more information, please visit www.tigerbeer.com/sg

#7Eleven #TigerBeer

Babel Finance Raises $80 Million in a Series B funding round, Valuation Hits $2 Billion

HONG KONG SAR – Media OutReach – 21 June 2022 – Babel Finance, a crypto financial service provider that provides digital asset loans, recently raised $80 million in a Series B funding round. The investment increased the company’s worth to $2 billion. Leading venture capital companies such as Circle Ventures, 10T Holdings, Jenerations Capital, BAI Capital and Bertelsmann, and Dragonfly Capital led the fundraising.

Babel Finance’s $80 million funding round is not its first. Last year, it secured $40 million from Tiger Global Management, Sequoia Capital China, Zoo Capital, and other big institutional investors.

Del Wang, the company’s CEO, commented on the move, saying that the crypto sector is “full of opportunities and hidden hazards.” The funding round also supports the long-term path for crypto, and that it has the potential to replace gold and its position in the present financial system, he believes.

For decades, gold investors have extolled the precious yellow metal as the ideal “store of value,” shielding their investments from the destructive effects of inflation. Then along comes Bitcoin. Some cryptocurrency supporters have recently claimed that crypto can keep up with growing prices better than gold. They say it will be even more independent of the dollar and other mainstream financial assets because it exists wholly outside the current financial system.

Traditionally, investors concerned about inflation and the loss of fiat currencies’ purchasing value have turned to gold. Because of its scarcity and durability, the argument is that gold is a greater store of value than paper money, which has an infinite supply and is backed by the government.

However, has gold been stable and a good store of value? In 2021, gold’s limitations as an inflation hedge were even more evident. Gold was down as consumer prices rose at their fastest rate since 2008. On the other hand, Bitcoin and many other crypto assets enjoyed growth in value, despite recent volatility.

Del Wang believes that Bitcoin and crypto assets will increasingly become mainstream for the financial assets industry and investors in general, citing that several financial institutions have already shifted from traditional commercial banking to the realm of crypto. As a result, Bitcoin, crypto assets, and gold should have a growing correlation.

Del Wang suggests that as crypto assets and Bitcoin become more widespread investments, investors would begin to regard both assets identically. In gold’s defense, some argue that volatility is crypto’s weakness. Gold and other precious metals are more conventional stores of value. In theory, they aren’t nearly as volatile as crypto and therefore are not likely to trade near zero in terms of value.

Del Wang and his Babel Finance crypto team looked into one indicator of an asset’s efficacy as a “store of value”: the Sortino ratio. It is a metric that modifies returns to account for volatility. According to a five-year chart on the casebitcoin.com website, Bitcoin has consistently outperformed gold’s Sortino ratio despite its reputation for increased volatility. So gold is very volatile, and Bitcoin’s rapid gains have made the increased risk worthwhile.

Evidence points out that there is potential that crypto assets and Bitcoin could replace gold and its position in the present financial system. Even during extremely volatile times, Bitcoin shines as a store of value over a medium to long-term horizon. Even more so than gold.

The issuer is solely responsible for the content of this announcement.

Body of Foreign National Found in Bokeo Province

A Chinese national was found dead floating in the river in Pak Tha district, Bokeo province.

Enriching Lives through Excellent Service Hang Lung Frontline Staff “Go the Extra Mile” to Show Their Commitment to Customer-Centricity Amid the Pandemic

HONG KONG SAR – Media OutReach20 June 2022 – Hang Lung Properties Limited (SEHK Stock Code: 00101) (the “Company” or “Hang Lung”) hosted its 2022 Hang Lung Emerald Award presentation ceremony, honoring frontline staff members for exemplifying the Hang Lung service philosophy of customer-centricity, and the We Do It Well motto through the provision of exceptional customer service.

Mr. Adriel Chan, Vice Chair (1st from the right), Mr. Weber Lo, Chief Executive Officer (2nd from the left) and senior management of Hang Lung Properties attend the 2022 Hang Lung Emerald Award presentation ceremony to commend frontline staff winners for upholding the service philosophy of customer-centric even amid the pandemic

Mr. Adriel Chan, Vice Chair of Hang Lung Properties, congratulated the winners and said, “Our frontline staff are an indispensable bridge between the Company, our customers and the communities we serve. At the heart of it, they communicate our vision, mission and values through actions that demonstrate their focus on customer-centricity. This year’s Emerald Award winners epitomize what it means to do it well in their vital roles, creating a Hang Lung branded experience to customers, and enriching lives through excellent service.”

Two Emerald Award-winning cases were honored at the ceremony, involving guest services and operational hygiene personnel from Kornhill Apartments in Hong Kong, and Riverside 66 in Tianjin. The first Emerald Award was present for actions with the rescue of a chronically-ill elderly resident living alone, while the second saw the staff member provide proactive assistance to two tourists who are enthusiastic photographers to take their desired photos. The two Emerald Award winning cases and those of the three Merit Award winners demonstrated service excellence in various circumstances, epitomizing the Hang Lung spirit of customer-centricity and “Go the Extra Mile”, which is at the very heart of the Hang Lung Emerald Award.

Mr. Weber Lo, Chief Executive Officer of Hang Lung Properties, said, “We are exceptionally proud of our people for delivering on our brand promise grounded in customer-centricity, and providing assistance from the perspectives of customers even amid the challenges presented by the COVID-19 pandemic in Hong Kong and mainland China.”

Hang Lung takes the “Go the Extra Mile” spirit beyond the provision of exceptional customer service to the community at large, through community investment initiatives like the “Love·No·Limit” program in collaboration with the Hong Kong Young Women’s Christian Association that seeks to build awareness of the needs of people living with dementia, and to equip staff with the skills necessary to provide quality service to people in need.

About Hang Lung Properties

Hang Lung Properties Limited (SEHK Stock Code: 00101) creates compelling spaces that enrich lives. Headquartered in Hong Kong, Hang Lung Properties develops and manages a diversified portfolio of world-class properties in Hong Kong and the nine Mainland cities of Shanghai, Shenyang, Jinan, Wuxi, Tianjin, Dalian, Kunming, Wuhan and Hangzhou. With its luxury positioning under the “66” brand, the company’s Mainland portfolio has established its leading position as the “Pulse of the City”. Hang Lung Properties is recognized for leading the way in enhanced sustainability initiatives in real estate as it pursues sustainable growth by connecting customers and communities.

At Hang Lung Properties – We Do It Well.

For more information, please visit .

#HangLungProperties

Grand Pharma’s Innovative Product for Liver Tumors, Y-90, Is Commercialized in Mainland China, Empowering “Nuclear Power” to The Company’s Performance

HONG KONG SAR – Media OutReach – 20 June 2022 – On 19 June, the technology innovation pharmaceutical company, Grand Pharmaceutical Group Limited (stock code: 0512.HK)’s global innovative product, SIR-Spheres® Y-90 microsphere injection for the treatment of liver malignant tumors, was officially commercialized in Mainland China. An innovative treatment method at the level of “nuclear weapons” is now available for patients with liver cancer in Mainland China.

“Super nuclear bomb” fills the gap in treatment and helps to overcome liver cancer

SIR-Spheres® Y-90 microsphere injection is a targeted internal radionuclide product for liver malignant tumors, applying the world’s leading interventional technology to inject Y-90 microsphere injection into the blood vessels of the liver tumors and release high-energy beta radiation to kill tumor cells. It is still the only product in the world for selective internal radiation therapy (SIRT) for colorectal cancer liver metastases.

During the 20 years since it was launched, Y-90 microsphere injection has treated more than 120,000 patients worldwide. Its clinical safety and efficacy have been widely recognized, and is recommended by the guidelines issued by different institutions. Since the beginning of this year, many grade-A primary hospitals in Tianjin, Shaanxi, Jiangsu, Hangzhou, Hunan, Liaoning, Haikou and other provinces and cities have successfully performed precision interventional surgery of Y-90 microsphere injection for many patients. At present, all patients that had interventional surgery have undergone SPECT examinations, which are in line with pre-treatment expectations.

As Y-90 gradually enters grade-A primary hospitals in Mainland China, the product will provide a new and effective treatment method for a large number of patients with liver malignant tumors in Mainland China, creating potential surgical resection opportunities, filling the gap in the local treatment of colorectal cancer liver metastases, and marking the landing of a new international precision interventional treatment plan in the field of liver malignant tumors in Mainland China.

Dong Jiahong, academician of the Chinese Academy of Engineering and president of Beijing Tsinghua Changgung Hospital affiliated to Tsinghua University, said: “Y-90 microsphere injection is like a ‘super nuclear bomb’ that can be accurately delivered to kill tumors. Precise manipulation of Y-90 microsphere injection can effectively control patients with advanced liver cancer. Some cases are expected to achieve the effect of downstaging treatment, thus creating opportunities for curative surgery such as liver resection or liver transplantation. It becomes a new blockbuster weapon to overcome liver cancer in Mainland China.”

Fan Jia, academician of the Chinese Academy of Sciences and president of Zhongshan Hospital affiliated to Fudan University, also pointed out that China is a big country with a large number of patients with liver cancer. The medical community has been constantly seeking new methods for the treatment of liver cancer. As a new treatment method for liver cancer, the introduction of Y-90 microsphere injection into the treatment method of Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition), will bring positive and important clinical significance to Chinese doctors and patients.

Grand Pharma strategically plans a whole industrial chain of radionuclide drugs based on Y-90

In addition to being a milestone in the history of liver cancer treatment in Mainland China, the Y-90 microsphere injection also has great value to Grand Pharma.

In recent years, Grand Pharma has been focusing on building its radiopharmaceutical diagnosis and treatment platform with the core of Y-90 microsphere injection. Currently, the Company has established a comprehensive layout in the field of research, production and commercialization worldwide, and three radiopharmaceutical R&D bases and five radiopharmaceutical production bases are set globally. The radiopharmaceutical diagnosis and treatment platform is currently one of the most globalized segments of the Company.

Grand Pharma’s radiopharmaceutical diagnosis and treatment platform now has reserved 10 innovative products, covering 6 nuclides including 68Ga, 177Lu, 131I, 90Y, 89Zr and 99mTc. In terms of indications, it covers 13 cancer types including liver cancer, prostate cancer, colorectal cancer, clear cell renal cell carcinoma, glioblastoma, gastroenteropancreatic neuroendocrine tumors and bone metastases of malignant tumors. Its product types cover two types of radionuclide drugs for diagnosis and treatment, providing patients with multi-indication treatment options, multi-method and integrated diagnosis and treatment of the world’s leading anti-tumor solutions.

From the perspective of market space, there are nearly 400,000 new cases of liver cancer and about 380,000 new cases of colorectal cancer in Mainland China every year, of which about 30-50% of colorectal cancer patients will develop liver metastasis. Most patients are already in the middle and late stages when they are discovered, and the existing treatment options are relatively limited. Y-90 microsphere injection will provide more treatment options for patients with liver cancer in Mainland China.

The official commercialization of Y-90 microsphere injection is an important step in the establishment of the radionuclide diagnosis and treatment platform of Grand Pharma. It is also expected to further improve the production and sales network of radionuclide drugs, and achieve comprehensive localized production in Mainland China. In the future, with the sales volume of innovative products of Y-90 microsphere injection increasing gradually, Grand Pharma’s performance is also expected to empower “nuclear power” and further increase the market value of its product pipeline.

Grand Pharma’s Innovative Product for Liver Tumors, Y-90, Is Commercialized in Mainland China, Empowering “Nuclear Power” to The Company’s Performance

HONG KONG SAR – Media OutReach – 20 June 2022 – On 19 June, the technology innovation pharmaceutical company, Grand Pharmaceutical Group Limited (stock code: 0512.HK)’s global innovative product, SIR-Spheres® Y-90 microsphere injection for the treatment of liver malignant tumors, was officially commercialized in Mainland China. An innovative treatment method at the level of “nuclear weapons” is now available for patients with liver cancer in Mainland China.

“Super nuclear bomb” fills the gap in treatment and helps to overcome liver cancer

SIR-Spheres® Y-90 microsphere injection is a targeted internal radionuclide product for liver malignant tumors, applying the world’s leading interventional technology to inject Y-90 microsphere injection into the blood vessels of the liver tumors and release high-energy beta radiation to kill tumor cells. It is still the only product in the world for selective internal radiation therapy (SIRT) for colorectal cancer liver metastases.

During the 20 years since it was launched, Y-90 microsphere injection has treated more than 120,000 patients worldwide. Its clinical safety and efficacy have been widely recognized, and is recommended by the guidelines issued by different institutions. Since the beginning of this year, many grade-A primary hospitals in Tianjin, Shaanxi, Jiangsu, Hangzhou, Hunan, Liaoning, Haikou and other provinces and cities have successfully performed precision interventional surgery of Y-90 microsphere injection for many patients. At present, all patients that had interventional surgery have undergone SPECT examinations, which are in line with pre-treatment expectations.

As Y-90 gradually enters grade-A primary hospitals in Mainland China, the product will provide a new and effective treatment method for a large number of patients with liver malignant tumors in Mainland China, creating potential surgical resection opportunities, filling the gap in the local treatment of colorectal cancer liver metastases, and marking the landing of a new international precision interventional treatment plan in the field of liver malignant tumors in Mainland China.

Dong Jiahong, academician of the Chinese Academy of Engineering and president of Beijing Tsinghua Changgung Hospital affiliated to Tsinghua University, said: “Y-90 microsphere injection is like a ‘super nuclear bomb’ that can be accurately delivered to kill tumors. Precise manipulation of Y-90 microsphere injection can effectively control patients with advanced liver cancer. Some cases are expected to achieve the effect of downstaging treatment, thus creating opportunities for curative surgery such as liver resection or liver transplantation. It becomes a new blockbuster weapon to overcome liver cancer in Mainland China.”

Fan Jia, academician of the Chinese Academy of Sciences and president of Zhongshan Hospital affiliated to Fudan University, also pointed out that China is a big country with a large number of patients with liver cancer. The medical community has been constantly seeking new methods for the treatment of liver cancer. As a new treatment method for liver cancer, the introduction of Y-90 microsphere injection into the treatment method of Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition), will bring positive and important clinical significance to Chinese doctors and patients.

Grand Pharma strategically plans a whole industrial chain of radionuclide drugs based on Y-90

In addition to being a milestone in the history of liver cancer treatment in Mainland China, the Y-90 microsphere injection also has great value to Grand Pharma.

In recent years, Grand Pharma has been focusing on building its radiopharmaceutical diagnosis and treatment platform with the core of Y-90 microsphere injection. Currently, the Company has established a comprehensive layout in the field of research, production and commercialization worldwide, and three radiopharmaceutical R&D bases and five radiopharmaceutical production bases are set globally. The radiopharmaceutical diagnosis and treatment platform is currently one of the most globalized segments of the Company.

Grand Pharma’s radiopharmaceutical diagnosis and treatment platform now has reserved 10 innovative products, covering 6 nuclides including 68Ga, 177Lu, 131I, 90Y, 89Zr and 99mTc. In terms of indications, it covers 13 cancer types including liver cancer, prostate cancer, colorectal cancer, clear cell renal cell carcinoma, glioblastoma, gastroenteropancreatic neuroendocrine tumors and bone metastases of malignant tumors. Its product types cover two types of radionuclide drugs for diagnosis and treatment, providing patients with multi-indication treatment options, multi-method and integrated diagnosis and treatment of the world’s leading anti-tumor solutions.

From the perspective of market space, there are nearly 400,000 new cases of liver cancer and about 380,000 new cases of colorectal cancer in Mainland China every year, of which about 30-50% of colorectal cancer patients will develop liver metastasis. Most patients are already in the middle and late stages when they are discovered, and the existing treatment options are relatively limited. Y-90 microsphere injection will provide more treatment options for patients with liver cancer in Mainland China.

The official commercialization of Y-90 microsphere injection is an important step in the establishment of the radionuclide diagnosis and treatment platform of Grand Pharma. It is also expected to further improve the production and sales network of radionuclide drugs, and achieve comprehensive localized production in Mainland China. In the future, with the sales volume of innovative products of Y-90 microsphere injection increasing gradually, Grand Pharma’s performance is also expected to empower “nuclear power” and further increase the market value of its product pipeline.